NCT02909049View on ClinicalTrials.gov

Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 24, 2018

Study Completion Date

January 24, 2018

Conditions

Prostatic Cancer

Interventions

DRUG

MIDAZOLAM

Intravenous bolus anesthesia 5 minutes previous to saturation prostate biopsy.

DRUG

MEPIVACAÍNE

Local periprostatic anesthesia infiltration, previous to saturation prostate biopsy.

DRUG

FENTANILE

Intravenous bolus anesthesia 3 minutes previous to saturation prostate biopsy.

DRUG

KETAMINE

Intravenous bolus anesthesia 1 minute previous to saturation prostate biopsy.

Trial Locations (1)

15006

Jose Luis Ponce Diaz-Reixa, A Coruña

All Listed Sponsors

lead

Complexo Hospitalario Universitario de A Coruña

OTHER

NCT02909049 - Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy | Biotech Hunter | Biotech Hunter